KRCA-0008

• Target :

  ALK|||Apoptosis|||ACK1

• Related Pathways :

  Tyrosine Kinase/Adaptors|||Angiogenesis|||Apoptosis

• Purity :

  0.9843

• Bioactivity :

  KRCA-0008 is an effective and specific ALK/Ack1 inhibitor (IC50: 12/4 nM) ; displays drug-like properties without hERG liability.

• Smiles :

  COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccc(cc2OC)N2CCN(CC2)C(C)=O)n1)N1CCN(CC1)C(C)=O

• Molecular Formula :

  C30H37ClN8O4

• Molecular Weight :

  609.12

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1472795-20-2